Last update Dec. 29, 2014
Very Low Risk
On latest update, no relevant published data related to excretion into breast milk were found.
It is a product that has only mild or few side-effects when used at normal dose.
The absorption from ingested mother's milk to the infant's plasma is hampered by a low oral bioavailability, with this being a reason for a nil or minimal plasma level in the infant, except in prematures or soon after birth when absorption would be higher.
We do not have alternatives for カルボシステイン since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM